Results of diffusion method (inhibition grown or minimum inhibitory quantity) of plant extracts and fractions against
\\n\\n
IntechOpen Book Series will also publish a program of research-driven Thematic Edited Volumes that focus on specific areas and allow for a more in-depth overview of a particular subject.
\\n\\nIntechOpen Book Series will be launching regularly to offer our authors and editors exciting opportunities to publish their research Open Access. We will begin by relaunching some of our existing Book Series in this innovative book format, and will expand in 2022 into rapidly growing research fields that are driving and advancing society.
\\n\\nLaunching 2021
\\n\\nArtificial Intelligence, ISSN 2633-1403
\\n\\nVeterinary Medicine and Science, ISSN 2632-0517
\\n\\nBiochemistry, ISSN 2632-0983
\\n\\nBiomedical Engineering, ISSN 2631-5343
\\n\\nInfectious Diseases, ISSN 2631-6188
\\n\\nPhysiology (Coming Soon)
\\n\\nDentistry (Coming Soon)
\\n\\nWe invite you to explore our IntechOpen Book Series, find the right publishing program for you and reach your desired audience in record time.
\\n\\nNote: Edited in October 2021
\\n"}]',published:!0,mainMedia:{caption:"",originalUrl:"/media/original/132"}},components:[{type:"htmlEditorComponent",content:'With the desire to make book publishing more relevant for the digital age and offer innovative Open Access publishing options, we are thrilled to announce the launch of our new publishing format: IntechOpen Book Series.
\n\nDesigned to cover fast-moving research fields in rapidly expanding areas, our Book Series feature a Topic structure allowing us to present the most relevant sub-disciplines. Book Series are headed by Series Editors, and a team of Topic Editors supported by international Editorial Board members. Topics are always open for submissions, with an Annual Volume published each calendar year.
\n\nAfter a robust peer-review process, accepted works are published quickly, thanks to Online First, ensuring research is made available to the scientific community without delay.
\n\nOur innovative Book Series format brings you:
\n\nIntechOpen Book Series will also publish a program of research-driven Thematic Edited Volumes that focus on specific areas and allow for a more in-depth overview of a particular subject.
\n\nIntechOpen Book Series will be launching regularly to offer our authors and editors exciting opportunities to publish their research Open Access. We will begin by relaunching some of our existing Book Series in this innovative book format, and will expand in 2022 into rapidly growing research fields that are driving and advancing society.
\n\nLaunching 2021
\n\nArtificial Intelligence, ISSN 2633-1403
\n\nVeterinary Medicine and Science, ISSN 2632-0517
\n\nBiochemistry, ISSN 2632-0983
\n\nBiomedical Engineering, ISSN 2631-5343
\n\nInfectious Diseases, ISSN 2631-6188
\n\nPhysiology (Coming Soon)
\n\nDentistry (Coming Soon)
\n\nWe invite you to explore our IntechOpen Book Series, find the right publishing program for you and reach your desired audience in record time.
\n\nNote: Edited in October 2021
\n'}],latestNews:[{slug:"intechopen-supports-asapbio-s-new-initiative-publish-your-reviews-20220729",title:"IntechOpen Supports ASAPbio’s New Initiative Publish Your Reviews"},{slug:"webinar-introduction-to-open-science-wednesday-18-may-1-pm-cest-20220518",title:"Webinar: Introduction to Open Science | Wednesday 18 May, 1 PM CEST"},{slug:"step-in-the-right-direction-intechopen-launches-a-portfolio-of-open-science-journals-20220414",title:"Step in the Right Direction: IntechOpen Launches a Portfolio of Open Science Journals"},{slug:"let-s-meet-at-london-book-fair-5-7-april-2022-olympia-london-20220321",title:"Let’s meet at London Book Fair, 5-7 April 2022, Olympia London"},{slug:"50-books-published-as-part-of-intechopen-and-knowledge-unlatched-ku-collaboration-20220316",title:"50 Books published as part of IntechOpen and Knowledge Unlatched (KU) Collaboration"},{slug:"intechopen-joins-the-united-nations-sustainable-development-goals-publishers-compact-20221702",title:"IntechOpen joins the United Nations Sustainable Development Goals Publishers Compact"},{slug:"intechopen-signs-exclusive-representation-agreement-with-lsr-libros-servicios-y-representaciones-s-a-de-c-v-20211123",title:"IntechOpen Signs Exclusive Representation Agreement with LSR Libros Servicios y Representaciones S.A. de C.V"},{slug:"intechopen-expands-partnership-with-research4life-20211110",title:"IntechOpen Expands Partnership with Research4Life"}]},book:{item:{type:"book",id:"10703",leadTitle:null,fullTitle:"Risk Factors for Cardiovascular Disease",title:"Risk Factors for Cardiovascular Disease",subtitle:null,reviewType:"peer-reviewed",abstract:"Risk Factors for Cardiovascular Disease raises awareness about the importance of early recognition and prevention of modifiable cardiovascular risk factors. Some non-modifiable factors, like diabetes, can even be impacted by lifestyle modification (like weight loss) early in the disease. This book also describes cardiovascular risk factors in different patient populations and work settings.",isbn:"978-1-83968-709-9",printIsbn:"978-1-83968-708-2",pdfIsbn:"978-1-83968-710-5",doi:"10.5772/intechopen.94673",price:119,priceEur:129,priceUsd:155,slug:"risk-factors-for-cardiovascular-disease",numberOfPages:228,isOpenForSubmission:!1,isInWos:null,isInBkci:!1,hash:"ce44a740aa9c4322a02614b2033deceb",bookSignature:"Johnny Chahine",publishedDate:"April 6th 2022",coverURL:"https://cdn.intechopen.com/books/images_new/10703.jpg",numberOfDownloads:1268,numberOfWosCitations:0,numberOfCrossrefCitations:0,numberOfCrossrefCitationsByBook:0,numberOfDimensionsCitations:0,numberOfDimensionsCitationsByBook:0,hasAltmetrics:1,numberOfTotalCitations:0,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"April 9th 2021",dateEndSecondStepPublish:"May 7th 2021",dateEndThirdStepPublish:"July 6th 2021",dateEndFourthStepPublish:"September 24th 2021",dateEndFifthStepPublish:"November 23rd 2021",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6",editedByType:"Edited by",kuFlag:!1,featuredMarkup:null,editors:[{id:"339234",title:"Dr.",name:"Johnny",middleName:null,surname:"Chahine",slug:"johnny-chahine",fullName:"Johnny Chahine",profilePictureURL:"https://mts.intechopen.com/storage/users/339234/images/system/339234.jpg",biography:"Dr. Chahine graduated from medical school in Lebanon in 2016 and moved to Cleveland, USA for his Internal Medicine residency in 2017. He is currently a cardiology fellow at the University of Minnesota, USA. He is well-published in high-impact journals. Dr. Chahine strives for excellence in his medical knowledge and a friendly environment for his colleagues and patients.",institutionString:"University of Minnesota",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"University of Minnesota",institutionURL:null,country:{name:"United States of America"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"170",title:"Cardiology and Cardiovascular Medicine",slug:"cardiology-and-cardiovascular-medicine"}],chapters:[{id:"78255",title:"Sex Differences in Long-Term Trends of Psychosocial Factors and Gender Effect on Risk of Cardiovascular Diseases: Arterial Hypertension, Myocardial Infarction and Stroke",doi:"10.5772/intechopen.99767",slug:"sex-differences-in-long-term-trends-of-psychosocial-factors-and-gender-effect-on-risk-of-cardiovascu",totalDownloads:122,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Introduction: The study aimed to determine gender differences in the prevalence and dynamics of affective states over a long period, i.e., 23 years, and to establish their effect on the risk of cardiovascular diseases (CVD), i.e., arterial hypertension (AH), myocardial infarction (MI), and stroke among the population aged 25–64 in Russia / Siberia. Methods: Between 1994 and 2017, we conducted 4 screening surveys of representative samples (totalling 4,815 people) under the international programs MONICA and HAPIEE in Russia / Siberia. To determine the sex differences in cardiovascular risk from 1994 to 2010, we observed cohorts formed from the screened individuals without CVD and diabetes mellitus (DM). Results: High levels of affective states in the period from 1994 to 2003, especially in women, were replaced by a downward trend in 2013. At the same time, there was a reduction in the gender gap in terms of frequency of depression lower 1%, and men in the younger age groups reported higher levels of personal anxiety (49.3% vs 46.1% in adults aged 35-44y) and vital exhaustion (16.9% vs 15.6%) than women in 2017. We found that men with unfavourable levels of affective states have a 3–5 fold higher risk of hypertension and stroke, while women have a higher risk of myocardial infarction (p for all < 0.05). Hostility in men is associated with a negative risk of myocardial infarction and stroke (HR=0.3 and HR=0.29, respectively; p for all < 0.05). However, this was levelled out by unfavourable social characteristics. Conclusions: The downward trends in prevalence of psychosocial factors were unstable and associated with reduced gender gap for affective states. It had a significant impact on the gender magnitude of cardiovascular risk.",signatures:"Valery V. Gafarov, Dmitriy O. Panov, Elena A. Gromova, Igor V. Gagulin, Almira V. Gafarova and Eldar A. Krymov",downloadPdfUrl:"/chapter/pdf-download/78255",previewPdfUrl:"/chapter/pdf-preview/78255",authors:[{id:"325050",title:"Dr.",name:"Elena A.",surname:"Gromova",slug:"elena-a.-gromova",fullName:"Elena A. Gromova"},{id:"325389",title:"Dr.",name:"Valery V.",surname:"Gafarov",slug:"valery-v.-gafarov",fullName:"Valery V. Gafarov"},{id:"325405",title:"Dr.",name:"Igor V.",surname:"Gagulin",slug:"igor-v.-gagulin",fullName:"Igor V. Gagulin"},{id:"343742",title:"Dr.",name:"Almira V.",surname:"Gafarova",slug:"almira-v.-gafarova",fullName:"Almira V. Gafarova"},{id:"416571",title:"Dr.",name:"Dmitriy O.",surname:"Panov",slug:"dmitriy-o.-panov",fullName:"Dmitriy O. Panov"},{id:"416572",title:"Dr.",name:"Eldar A.",surname:"Krymov",slug:"eldar-a.-krymov",fullName:"Eldar A. Krymov"}],corrections:null},{id:"78472",title:"Vascular Calcification and Cardiovascular Risk in Chronic Kidney Disease: A Problem That Is Here to Stay",doi:"10.5772/intechopen.99886",slug:"vascular-calcification-and-cardiovascular-risk-in-chronic-kidney-disease-a-problem-that-is-here-to-s",totalDownloads:141,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Cardiovascular disease is the primary cause of morbidity and mortality in chronic kidney disease (CKD) population, particularly in end stage renal disease (ESRD). This could be explained in part due to the presence of traditional cardiovascular risk factors, such as older age, hypertension, dyslipidemia and diabetes, but is also associated with nontraditional cardiovascular risk factors related to CKD, like inflammation, anemia, abnormal calcium and phosphate metabolism and extracellular fluid volume overload, which may contribute to intimal or medial wall arterial calcification. Vascular calcification (VC) is a dynamic process, resulting from the dysregulation of the balance of molecules that promote and those that inhibit this course. It is important for clinicians to both acknowledge and recognize the pathways and risk factors of VC in order to improve cardiovascular health in CKD patients. This chapter will focus on the biology of VC, the association with CKD, risk factor modification, screening and prevention of VC and cardiovascular disease in CKD patients.",signatures:"Eduarda Castanheiro Esteves Carias, Roberto Calças Marques and Ana Paula Andrade da Silva",downloadPdfUrl:"/chapter/pdf-download/78472",previewPdfUrl:"/chapter/pdf-preview/78472",authors:[{id:"201700",title:"Dr.",name:"Ana Paula",surname:"Andrade da Silva",slug:"ana-paula-andrade-da-silva",fullName:"Ana Paula Andrade da Silva"},{id:"422802",title:"Dr.",name:"Eduarda",surname:"Castanheiro Esteves Carias",slug:"eduarda-castanheiro-esteves-carias",fullName:"Eduarda Castanheiro Esteves Carias"},{id:"425915",title:"Dr.",name:"Roberto",surname:"Calças Marques",slug:"roberto-calcas-marques",fullName:"Roberto Calças Marques"}],corrections:null},{id:"78930",title:"Genetic Polymorphisms and Their Interactions with the Risk Factors of Cardiovascular Diseases: Review Chapter",doi:"10.5772/intechopen.100486",slug:"genetic-polymorphisms-and-their-interactions-with-the-risk-factors-of-cardiovascular-diseases-review",totalDownloads:92,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:1,abstract:"Cardiovascular diseases (CVDs) have been reported to have a complex pathogenesis by a number of studies. Atherosclerosis and inflammation have been established as the main contributors to CVDs. Furthermore, genetic polymorphisms have been identified and found to have a correlation with an individual’s susceptibility to developing CVD. Some of these polymorphisms and corresponding cardiovascular risk (CVR) factors include: C174G (Interleukin (IL)-6 association), methylenetetrahydrofolate reductase (MTHFR) C667T/A1298C (hyperhomocysteinaemia), VII R353Q (coagulation factor VII association) and rs247616/rs1968905/rs1270922 (cholesteryl ester transfer protein (CEPT) - cholesterol metabolism) amongst others. At a time when disease prediction, diagnosis and prognosis are still being investigated, these polymorphisms have the potential for use in these areas as well as opening more opportunities in the understanding of CVD. The objective of this chapter was to review the current knowledge about the relationship between genetic polymorphisms and cardiovascular disease.",signatures:"Joseph Musonda Chalwe, Christa Grobler and Wilna Oldewage-Theron",downloadPdfUrl:"/chapter/pdf-download/78930",previewPdfUrl:"/chapter/pdf-preview/78930",authors:[{id:"337007",title:"Prof.",name:"Wilna",surname:"Oldewage-Theron",slug:"wilna-oldewage-theron",fullName:"Wilna Oldewage-Theron"},{id:"337009",title:"Dr.",name:"Christa",surname:"Grobler",slug:"christa-grobler",fullName:"Christa Grobler"},{id:"435595",title:"Mr.",name:"Joseph",surname:"MusondaChalwe",slug:"joseph-musondachalwe",fullName:"Joseph MusondaChalwe"}],corrections:null},{id:"78781",title:"Risk Factors for Cardiovascular Diseases in Aircrew",doi:"10.5772/intechopen.99905",slug:"risk-factors-for-cardiovascular-diseases-in-aircrew",totalDownloads:140,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"The relation of atherosclerotic cardiovascular disease (ASCVD) to not only traditional but also new and emergent risk factors has been assessed in aircrew. Total flight hours (TFH), high altitude and weightlessness exposure have been accounted among traditional risk factors for CVD among the aircrew. The risk factors do not perform in loneliness. To predict the 10 years global CV risk, several scores are being applied either based on traditional CVD risk factors only or also including new and emergent risk factors. To prevent aircrew from developing CVD, one should focus on the control of behavioral and metabolic risks as well as the polymorphe treatment of high CV risk individuals.",signatures:"Nathan B. Buila, Gilbert K. Kabanda, Elysee M-C. Munyoka, Jean-Marc B. Bantu and Jean René M’Buyamba-Kabangu",downloadPdfUrl:"/chapter/pdf-download/78781",previewPdfUrl:"/chapter/pdf-preview/78781",authors:[{id:"417444",title:"Dr.",name:"Nathan",surname:"B. Buila",slug:"nathan-b.-buila",fullName:"Nathan B. Buila"},{id:"419134",title:"Prof.",name:"Jean René",surname:"M’Buyamba-Kabangu",slug:"jean-rene-m'buyamba-kabangu",fullName:"Jean René M’Buyamba-Kabangu"},{id:"419135",title:"Dr.",name:"Gilbert K.",surname:"Kabanda",slug:"gilbert-k.-kabanda",fullName:"Gilbert K. Kabanda"},{id:"429256",title:"Dr.",name:"Jean-Marc",surname:"B. Bantu",slug:"jean-marc-b.-bantu",fullName:"Jean-Marc B. Bantu"},{id:"429257",title:"Dr.",name:"Elysée",surname:"M-C. Munyoka",slug:"elysee-m-c.-munyoka",fullName:"Elysée M-C. Munyoka"}],corrections:null},{id:"78608",title:"Cardiovascular Risk Factors in Children",doi:"10.5772/intechopen.99729",slug:"cardiovascular-risk-factors-in-children",totalDownloads:129,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Cardiovascular morbidity and mortality are still increasing in developed countries with emphasis on the obesity epidemic. Children and young adults are no exception. With modern lifestyle, traditional cardiovascular risk factors, such as hypertension, obesity, dyslipidemia, insulin resistance, kidney damage, are increasingly present in children leading to premature cardiovascular events in adult life. Cardiovascular risk factor can accelerate naturally progressing atherosclerosis, which should be prevented to facilitate quality and longevity of life. Primary and primordial prevention in the pediatric population are of utmost importance. However, if a cardiovascular risk factor is already present, frequent monitoring of possible development of other cardiovascular risk factors and evaluation of end organ damage should be implemented to intervene in time.",signatures:"Mirjam Močnik and Nataša Marčun Varda",downloadPdfUrl:"/chapter/pdf-download/78608",previewPdfUrl:"/chapter/pdf-preview/78608",authors:[{id:"415435",title:"M.D.",name:"Mirjam",surname:"Močnik",slug:"mirjam-mocnik",fullName:"Mirjam Močnik"},{id:"415436",title:"Prof.",name:"Nataša",surname:"Marčun Varda",slug:"natasa-marcun-varda",fullName:"Nataša Marčun Varda"}],corrections:null},{id:"78707",title:"Role of Arterial Pressure, Wall Stiffness, Pulse Pressure and Waveform in Arterial Wall Stress/Strain and Its Clinical Implications",doi:"10.5772/intechopen.100048",slug:"role-of-arterial-pressure-wall-stiffness-pulse-pressure-and-waveform-in-arterial-wall-stress-strain-",totalDownloads:127,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Biomechanical stress applied to the intima of arteries has long been suspected as a factor in the initiation and localisation of atherosclerotic plaque, and it is implicated in the separation of plaque from the underlying arterial wall giving rise to the acute clinical consequences of thrombosis, dissection and embolism. The factors underlying transmural stress were investigated in-vitro using fresh porcine abdominal aortas on an experimental rig in which pulse pressure, pulse waveform, fluid viscosity, pulse rate, vessel wall compliance and systolic and diastolic blood pressure could be varied at will. Vessel wall compliance was progressively reduced by exposure of the artery to formaldehyde vapour for increased periods of time, a saline-treated artery being used as control. Centripetal transmural stress (CTS) and strain were studied by direct observation of the displacement of a compliant false intima (FI) using real-time B and M mode ultrasound, and by measuring the differential pressure between the space beneath the FI and the adjacent vessel lumen. CTS was found to be directly related to pulse pressure (r = 0.907, p < 0.001) and inversely related to vessel wall compliance. It was independently affected by ranked peak pressure waveform (R = 0.93, p < 0.01) being higher with sharp peak pressure and lower when the waveform was rounded, and it peaked in early diastole in untreated vessels, and both in diastole and peak systole in ones stiffened by formaldehyde vapour. Mean arterial pressure exerted a profound effect via its effect on vessel wall stiffness, which was found to rise 7-fold across the mean arterial pressure range 50-130 mmHg and continued to increase in a logarithmic fashion as the upper physiological range of mean arterial pressure was exceeded. There are two potential clinical implications: in mitigating the postulated biomechanical aspects atherogenesis and atherosclerotic plaque detachment, maintaining large vessel wall compliance is important, and the main factor determining this in a healthy artery is mean arterial pressure; if the arterial wall has already become stiffened as a result of disease, and in the absence of critical stenosis, the findings suggest that the appropriate therapeutic targets are modification of pulse pressure and pulse waveform profile. Simply reducing the diastolic pressure in elderly patients may be unwise if the result is a widened pulse pressure and increased transmural strain. The distribution of atheroma at points of focal mechanical strain in the vessel wall may be explicable if the stress induced by an excessive pulse pressure provokes the inflammatory changes seen in repetitive strain injury. Investigation of inflammatory signalling in the vessel wall provoked by repeated mechanical stress may represent a productive area for future research.",signatures:"Thomas K. Day",downloadPdfUrl:"/chapter/pdf-download/78707",previewPdfUrl:"/chapter/pdf-preview/78707",authors:[{id:"414115",title:"Dr.",name:"Thomas K.",surname:"Day",slug:"thomas-k.-day",fullName:"Thomas K. Day"}],corrections:null},{id:"78134",title:"Importance of Resistance Training in the Management of Cardiovascular Disease Risk",doi:"10.5772/intechopen.99710",slug:"importance-of-resistance-training-in-the-management-of-cardiovascular-disease-risk",totalDownloads:167,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Contrary to the longstanding taboo of resistance training (RT) as a therapeutic treatment, RT has been gaining importance as a safe therapeutic option in the management of numerous diseases. Although exercise has well-documented health benefits on cardiovascular disease (CVD), the benefit of RT on CVD risk factors is not yet as widely prescribed as other modes of exercise. Due to its efficacy in the management of CVD, RT should be regarded as a complementary therapeutic treatment rather than a substitute to other modes of exercise therapy. While it is clear that RT can result in an attenuation of CVD risk, the various RT design options related to intensity and volume and how they impact on CVD risk, especially in different populations (i.e. children, elderly, women) is not yet well documented. This chapter will discuss the physiological phenomenon and benefits of RT as a therapeutic intervention aiming to manage CVD risk.",signatures:"Brandon S. Shaw, Gregory A. Brown and Ina Shaw",downloadPdfUrl:"/chapter/pdf-download/78134",previewPdfUrl:"/chapter/pdf-preview/78134",authors:[{id:"415438",title:"Prof.",name:"Ina",surname:"Shaw",slug:"ina-shaw",fullName:"Ina Shaw"},{id:"416529",title:"Prof.",name:"Brandon S.",surname:"Shaw",slug:"brandon-s.-shaw",fullName:"Brandon S. Shaw"},{id:"421864",title:"Prof.",name:"Gregory A.",surname:"Brown",slug:"gregory-a.-brown",fullName:"Gregory A. Brown"}],corrections:null},{id:"78289",title:"The Effects of Linoleic Acid Consumption on Lipid Risk Markers for Cardiovascular Disease",doi:"10.5772/intechopen.99894",slug:"the-effects-of-linoleic-acid-consumption-on-lipid-risk-markers-for-cardiovascular-disease",totalDownloads:127,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:1,abstract:"Cardiovascular disease (CVD) is the number one contributor to death in the United States and worldwide. Lipid risk markers for CVD include high serum concentrations of total cholesterol, low-density lipoprotein cholesterol (LDL-C), very-low-density lipoprotein cholesterol (VLDL-C), lipoprotein (a), and triglycerides, as well as low serum concentrations of high-density lipoprotein cholesterol (HDL-C). Additional factors to assess CVD risk include apolipoprotein A (associated with HDL) and apolipoprotein B (associated with LDL). A suggested dietary strategy to decrease these risk factors is to replace a portion of saturated fatty acids with unsaturated fatty acids – especially polyunsaturated fatty acids (PUFAs). One PUFA, in particular, is the essential omega-6 PUFA linoleic acid, which has been demonstrated to affect these CVD risk markers. Therefore, this chapter will discuss the effects of linoleic acid consumption on lipid risk markers for CVD in healthy individuals, the associated mechanisms, and dietary recommendations to decrease CVD risk.",signatures:"Erik Froyen",downloadPdfUrl:"/chapter/pdf-download/78289",previewPdfUrl:"/chapter/pdf-preview/78289",authors:[{id:"415310",title:"Assistant Prof.",name:"Erik",surname:"Froyen",slug:"erik-froyen",fullName:"Erik Froyen"}],corrections:null},{id:"78748",title:"Residual Cardiovascular Risk Factors in Dyslipidemia",doi:"10.5772/intechopen.100046",slug:"residual-cardiovascular-risk-factors-in-dyslipidemia",totalDownloads:88,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Cardiovascular disease poses a major challenge for the 21st century. Although good control of blood pressure and type 2 diabetes and reducing low-density lipoprotein-cholesterol levels can improve cardiovascular outcomes, a substantial residual risk remains existed after treatment in most patient populations. Recently, many efforts have been directed at finding the important role of low high-density-lipoprotein cholesterol, high triglycerides, especially triglyceride-rich lipoproteins and lipoprotein (a) in the metabolism of atherosclerotic plaque formation Therefore, based on the recent evidence, identification and treatment of these risk factors may play a role in optimizing therapeutic strategy, particularly in high risk subjects along with conventional treatment. In clinical practice, adequate attention should be paid when screening and managing residual cardiovascular risk factors in dyslipidemia in term of individualized approach. The ongoing trials will give more answers to elucidate this important area.",signatures:"Van Si Nguyen, Xuan Truong Tran, Thanh Duy Vo and Quang Truong Le",downloadPdfUrl:"/chapter/pdf-download/78748",previewPdfUrl:"/chapter/pdf-preview/78748",authors:[{id:"417878",title:"Ph.D.",name:"Van",surname:"Si Nguyen",slug:"van-si-nguyen",fullName:"Van Si Nguyen"},{id:"426384",title:"Dr.",name:"Xuan",surname:"Truong Tran",slug:"xuan-truong-tran",fullName:"Xuan Truong Tran"},{id:"426385",title:"Mr.",name:"Thanh",surname:"Duy Vo",slug:"thanh-duy-vo",fullName:"Thanh Duy Vo"},{id:"429531",title:"Dr.",name:"Quang Truong",surname:"Le",slug:"quang-truong-le",fullName:"Quang Truong Le"}],corrections:null},{id:"79957",title:"Experimental Model of Cardiotoxicity",doi:"10.5772/intechopen.101401",slug:"experimental-model-of-cardiotoxicity",totalDownloads:135,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"The occurrence of heart electrophysiology dysfunction or/and muscle damage is referred to as cardiotoxicity. The heart weakens and becomes less efficient at pumping and hence circulating blood. Cardiomyopathy can be caused by a variety of factors, including viral infections, diseases such as diabetes, ischemia, hypertension, obesity, radiation therapy, antipsychotic drugs, cytotoxic drugs, most notably chemotherapeutic agents; antitumor antibiotics, monoclonal antibodies, tyrosine kinase inhibitors, platinum-based compounds, microtubule inhibitors, vinca alkaloids, antimetabolites, proteasome inhibitors, topoisomerase inhibitors, alkylating agents, corticosteroids. This chapter focuses on the mechanisms of cardiotoxicity, animal models and transgenic methods used in studies, and the effects of therapeutic agents on cardiotoxicity.",signatures:"Oytun Erbaş, İlknur Altuntaş, Özge Çağlar, Elif Özyilmaz, Ece Sari, İlayda Üzümcü and Kaan Erbakan",downloadPdfUrl:"/chapter/pdf-download/79957",previewPdfUrl:"/chapter/pdf-preview/79957",authors:[{id:"345970",title:"Dr.",name:"İlknur",surname:"Altuntaş",slug:"ilknur-altuntas",fullName:"İlknur Altuntaş"},{id:"428475",title:"Prof.",name:"Oytun",surname:"Erbas",slug:"oytun-erbas",fullName:"Oytun Erbas"},{id:"428624",title:"B.Sc.",name:"Ece",surname:"Sarı",slug:"ece-sari",fullName:"Ece Sarı"},{id:"437888",title:"Dr.",name:"Özge",surname:"Çağlar",slug:"ozge-caglar",fullName:"Özge Çağlar"},{id:"437890",title:"Prof.",name:"Elif",surname:"Özyilmaz",slug:"elif-ozyilmaz",fullName:"Elif Özyilmaz"},{id:"437894",title:"Dr.",name:"İlayda",surname:"Üzümcü",slug:"ilayda-uzumcu",fullName:"İlayda Üzümcü"},{id:"437896",title:"Dr.",name:"Kaan",surname:"Erbakan",slug:"kaan-erbakan",fullName:"Kaan Erbakan"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},subseries:null,tags:null},relatedBooks:[{type:"book",id:"6209",title:"Endothelial Dysfunction",subtitle:"Old Concepts and New Challenges",isOpenForSubmission:!1,hash:"f6e76bbf7858977527679a6e6ad6a173",slug:"endothelial-dysfunction-old-concepts-and-new-challenges",bookSignature:"Helena Lenasi",coverURL:"https://cdn.intechopen.com/books/images_new/6209.jpg",editedByType:"Edited by",editors:[{id:"68746",title:"Dr.",name:"Helena",surname:"Lenasi",slug:"helena-lenasi",fullName:"Helena Lenasi"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6373",title:"Myocardial Infarction",subtitle:null,isOpenForSubmission:!1,hash:"10bca0bf18d68ec3c1641dbc3a1ae899",slug:"myocardial-infarction",bookSignature:"Burak Pamukçu",coverURL:"https://cdn.intechopen.com/books/images_new/6373.jpg",editedByType:"Edited by",editors:[{id:"70686",title:"Dr.",name:"Burak",surname:"Pamukçu",slug:"burak-pamukcu",fullName:"Burak Pamukçu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7556",title:"Dyslipidemia",subtitle:null,isOpenForSubmission:!1,hash:"dfd1faefe925f0f8335c42cdb36256c1",slug:"dyslipidemia",bookSignature:"Samy I. McFarlane",coverURL:"https://cdn.intechopen.com/books/images_new/7556.jpg",editedByType:"Edited by",editors:[{id:"53477",title:null,name:"Samy I.",surname:"McFarlane",slug:"samy-i.-mcfarlane",fullName:"Samy I. McFarlane"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6777",title:"Advances in Extra-corporeal Perfusion Therapies",subtitle:null,isOpenForSubmission:!1,hash:"1e52fb6e834ada962495c512111f684e",slug:"advances-in-extra-corporeal-perfusion-therapies",bookSignature:"Michael S. Firstenberg",coverURL:"https://cdn.intechopen.com/books/images_new/6777.jpg",editedByType:"Edited by",editors:[{id:"64343",title:"Dr.",name:"Michael S.",surname:"Firstenberg",slug:"michael-s.-firstenberg",fullName:"Michael S. Firstenberg"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7842",title:"Basic and Clinical Understanding of Microcirculation",subtitle:null,isOpenForSubmission:!1,hash:"a57d5a701b51d9c8e17b1c80bc0d52e5",slug:"basic-and-clinical-understanding-of-microcirculation",bookSignature:"Kaneez Fatima Shad, Seyed Soheil Saeedi Saravi and Nazar Luqman Bilgrami",coverURL:"https://cdn.intechopen.com/books/images_new/7842.jpg",editedByType:"Edited by",editors:[{id:"31988",title:"Prof.",name:"Kaneez",surname:"Fatima Shad",slug:"kaneez-fatima-shad",fullName:"Kaneez Fatima Shad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6752",title:"Cholesterol",subtitle:"Good, Bad and the Heart",isOpenForSubmission:!1,hash:"599b1f8bc760449a4ee6ecd816a1df93",slug:"cholesterol-good-bad-and-the-heart",bookSignature:"Madan L. Nagpal",coverURL:"https://cdn.intechopen.com/books/images_new/6752.jpg",editedByType:"Edited by",editors:[{id:"182681",title:"Dr.",name:"Madan L.",surname:"Nagpal",slug:"madan-l.-nagpal",fullName:"Madan L. Nagpal"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6158",title:"Atherosclerosis",subtitle:"Yesterday, Today and Tomorrow",isOpenForSubmission:!1,hash:"b4e6172f3280b85d9db8a3d88e1a1eeb",slug:"atherosclerosis-yesterday-today-and-tomorrow",bookSignature:"Luigi Gianturco",coverURL:"https://cdn.intechopen.com/books/images_new/6158.jpg",editedByType:"Edited by",editors:[{id:"208539",title:"Dr.",name:"Luigi",surname:"Gianturco",slug:"luigi-gianturco",fullName:"Luigi Gianturco"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6311",title:"Blood Pressure",subtitle:"From Bench to Bed",isOpenForSubmission:!1,hash:"2e393b1d66ff57ba49a6e00a6f50714d",slug:"blood-pressure-from-bench-to-bed",bookSignature:"Aise Seda Artis",coverURL:"https://cdn.intechopen.com/books/images_new/6311.jpg",editedByType:"Edited by",editors:[{id:"99453",title:"Dr.",name:"Aise Seda",surname:"Artis",slug:"aise-seda-artis",fullName:"Aise Seda Artis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8204",title:"Vascular Malformations of the Central Nervous System",subtitle:null,isOpenForSubmission:!1,hash:"2b6a8a26a78af3ac73731663a494fbad",slug:"vascular-malformations-of-the-central-nervous-system",bookSignature:"Bora Gürer and Pinar Kuru Bektaşoğlu",coverURL:"https://cdn.intechopen.com/books/images_new/8204.jpg",editedByType:"Edited by",editors:[{id:"95341",title:"Prof.",name:"Bora",surname:"Gürer",slug:"bora-gurer",fullName:"Bora Gürer"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8629",title:"Visions of Cardiomyocyte",subtitle:"Fundamental Concepts of Heart Life and Disease",isOpenForSubmission:!1,hash:"1cae2b319d6f3c230849834f10715701",slug:"visions-of-cardiomyocyte-fundamental-concepts-of-heart-life-and-disease",bookSignature:"Angelos Tsipis",coverURL:"https://cdn.intechopen.com/books/images_new/8629.jpg",editedByType:"Edited by",editors:[{id:"77462",title:"Dr.",name:"Angelos",surname:"Tsipis",slug:"angelos-tsipis",fullName:"Angelos Tsipis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"79356",slug:"correction-to-chemical-composition-and-biological-activities-of-mentha-species",title:"Correction to: Chemical Composition and Biological Activities of Mentha Species",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/57158.pdf",downloadPdfUrl:"/chapter/pdf-download/57158",previewPdfUrl:"/chapter/pdf-preview/57158",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/57158",risUrl:"/chapter/ris/57158",chapter:{id:"54028",slug:"chemical-composition-and-biological-activities-of-mentha-species",signatures:"Fatiha Brahmi, Madani Khodir, Chibane Mohamed and Duez Pierre",dateSubmitted:"June 7th 2016",dateReviewed:"December 19th 2016",datePrePublished:null,datePublished:"March 15th 2017",book:{id:"5612",title:"Aromatic and Medicinal Plants",subtitle:"Back to Nature",fullTitle:"Aromatic and Medicinal Plants - Back to Nature",slug:"aromatic-and-medicinal-plants-back-to-nature",publishedDate:"March 15th 2017",bookSignature:"Hany A. El-Shemy",coverURL:"https://cdn.intechopen.com/books/images_new/5612.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"54719",title:"Prof.",name:"Hany",middleName:null,surname:"El-Shemy",slug:"hany-el-shemy",fullName:"Hany El-Shemy"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"193281",title:"Dr.",name:"Fatiha",middleName:null,surname:"Brahmi",fullName:"Fatiha Brahmi",slug:"fatiha-brahmi",email:"fatiha.brahmi@univ-bejaia.dz",position:null,institution:{name:"University of Béjaïa",institutionURL:null,country:{name:"Algeria"}}},{id:"199693",title:"Prof.",name:"Khodir",middleName:null,surname:"Madani",fullName:"Khodir Madani",slug:"khodir-madani",email:"madani28dz@yahoo.fr",position:null,institution:null},{id:"199694",title:"Prof.",name:"Pierre",middleName:null,surname:"Duez",fullName:"Pierre Duez",slug:"pierre-duez",email:"pduez@umons.be",position:null,institution:null},{id:"203738",title:"Prof.",name:"Mohamed",middleName:null,surname:"Chibane",fullName:"Mohamed Chibane",slug:"mohamed-chibane",email:"chibanem@yahoo.fr",position:null,institution:null}]}},chapter:{id:"54028",slug:"chemical-composition-and-biological-activities-of-mentha-species",signatures:"Fatiha Brahmi, Madani Khodir, Chibane Mohamed and Duez Pierre",dateSubmitted:"June 7th 2016",dateReviewed:"December 19th 2016",datePrePublished:null,datePublished:"March 15th 2017",book:{id:"5612",title:"Aromatic and Medicinal Plants",subtitle:"Back to Nature",fullTitle:"Aromatic and Medicinal Plants - Back to Nature",slug:"aromatic-and-medicinal-plants-back-to-nature",publishedDate:"March 15th 2017",bookSignature:"Hany A. El-Shemy",coverURL:"https://cdn.intechopen.com/books/images_new/5612.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"54719",title:"Prof.",name:"Hany",middleName:null,surname:"El-Shemy",slug:"hany-el-shemy",fullName:"Hany El-Shemy"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"193281",title:"Dr.",name:"Fatiha",middleName:null,surname:"Brahmi",fullName:"Fatiha Brahmi",slug:"fatiha-brahmi",email:"fatiha.brahmi@univ-bejaia.dz",position:null,institution:{name:"University of Béjaïa",institutionURL:null,country:{name:"Algeria"}}},{id:"199693",title:"Prof.",name:"Khodir",middleName:null,surname:"Madani",fullName:"Khodir Madani",slug:"khodir-madani",email:"madani28dz@yahoo.fr",position:null,institution:null},{id:"199694",title:"Prof.",name:"Pierre",middleName:null,surname:"Duez",fullName:"Pierre Duez",slug:"pierre-duez",email:"pduez@umons.be",position:null,institution:null},{id:"203738",title:"Prof.",name:"Mohamed",middleName:null,surname:"Chibane",fullName:"Mohamed Chibane",slug:"mohamed-chibane",email:"chibanem@yahoo.fr",position:null,institution:null}]},book:{id:"5612",title:"Aromatic and Medicinal Plants",subtitle:"Back to Nature",fullTitle:"Aromatic and Medicinal Plants - Back to Nature",slug:"aromatic-and-medicinal-plants-back-to-nature",publishedDate:"March 15th 2017",bookSignature:"Hany A. El-Shemy",coverURL:"https://cdn.intechopen.com/books/images_new/5612.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"54719",title:"Prof.",name:"Hany",middleName:null,surname:"El-Shemy",slug:"hany-el-shemy",fullName:"Hany El-Shemy"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"11317",leadTitle:null,title:"Trichoderma - Technology and Uses",subtitle:null,reviewType:"peer-reviewed",abstract:"\r\n\tThe book Trichoderma aims to assist in the integrated management of plant diseases with applications in all cultivation systems (including vegetables, cereals, oilseeds and fruit trees). Parasitism, identification of species, ultrastructure and molecular aspects (uses of SSR and snips techniques) of the interaction of the biocontrol agent and the seeds, roots and the phyllosphere will also be discussed, taking into account all the modalities of use of this important and versatile microorganism. Aspects of its application involving products and their formulations for use by farmers, as well as management tactics involving other biocontrol agents such as bacteria, use of organic matter, vegetation cover and resistant or tolerant varieties for some pathosystem will also be addressed.
\r\n\r\n\tThe book will discuss integrated management of plant diseases and plant protection, with an emphasis on phytopathogenic fungi, biocontrol, plant genetics and resistance.
",isbn:"978-1-80355-355-9",printIsbn:"978-1-80355-354-2",pdfIsbn:"978-1-80355-356-6",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!1,isSalesforceBook:!1,isNomenclature:!1,hash:"adeba4522858a6406df7ad737a4f1956",bookSignature:"Dr. Fernando Cezar Cezar Juliatti",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/11317.jpg",keywords:"Mechanisms of Trichoderma Species, Morphology, Identification, Molecular Techniques, Uses and Field Application, Bioprospecting, Systemic Acquired Resistance (SAR), Resistance, Fungicides, Integrated Pest Management (IPM), Biocontrol, Application Modes",numberOfDownloads:342,numberOfWosCitations:0,numberOfCrossrefCitations:0,numberOfDimensionsCitations:0,numberOfTotalCitations:0,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"September 3rd 2021",dateEndSecondStepPublish:"October 1st 2021",dateEndThirdStepPublish:"November 30th 2021",dateEndFourthStepPublish:"February 18th 2022",dateEndFifthStepPublish:"April 19th 2022",dateConfirmationOfParticipation:null,remainingDaysToSecondStep:"10 months",secondStepPassed:!0,areRegistrationsClosed:!0,currentStepOfPublishingProcess:5,editedByType:null,kuFlag:!1,biosketch:"Dr. Juliatti is the Professor and Researcher at the Federal University of Uberlândia and President of the Brazilian Association of Agriculture Education. He is a Winner of the 2011 Top Ethanol Award and Winner of the Top Science Award in 2008 and 2013.",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"146372",title:"Dr.",name:"Fernando",middleName:"Cezar",surname:"Cezar Juliatti",slug:"fernando-cezar-juliatti",fullName:"Fernando Cezar Juliatti",profilePictureURL:"https://mts.intechopen.com/storage/users/146372/images/system/146372.png",biography:"Fernando Cezar Juliatti is an agronomist with a master\\'s degree in Phytopathology and a Ph.D. in Agronomy, Plant Breeding. He is currently a full professor at the Federal University of Uberlândia (UFU), where he has held the chair of phytopathology since 1987. He was previously director of the Institute of Agricultural Sciences and coordinator of the agronomy course at the same university. He is a member of the Chamber of Agronomy at the Amparo Research Foundation in Minas Gerais (FAPEMIG). He has published more than 220 articles in specialized journals in agronomy, plant pathology, biology, genetics, and plant breeding. He actively participates in scientific committees in Brazil, such as the Coordination of Improvement of Higher Education Personnel Foundation (CAPES), the National Council for Scientific and Technological Development (CNPq), and FAPEMIG. He twice composed the CAPES-Brazil award judging committee for the best doctoral theses in Brazil in biology, medicine, biochemistry, genetics and biotechnology, veterinary, food science, and agronomy. He has guided students awarded as winners of best works in scientific congresses and meetings. Dr. Juliatti won the Top Ethanol award from the Union of Alcohol and Sugar Industries (UNICA) in 2011. He was president of the Brazilian Society of Phytopathology in 2004 and president of the Golden Jubilee of the Brazilian Congress of Phytopathology in 2017. His research focuses on the alternative management of aggressive fungi in plants with the use of Trichoderma.",institutionString:"Federal University of Uberlândia",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"4",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Federal University of Uberlândia",institutionURL:null,country:{name:"Brazil"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"366",title:"Mycetology",slug:"mycetology"}],chapters:[{id:"80375",title:"Trichoderma: A Biofertilizer and a Bio-Fungicide for Sustainable Crop Production",slug:"trichoderma-a-biofertilizer-and-a-bio-fungicide-for-sustainable-crop-production",totalDownloads:151,totalCrossrefCites:0,authors:[null]},{id:"81107",title:"Can Genus Trichoderma Manage Plant Diseases under Organic Agriculture?",slug:"can-genus-trichoderma-manage-plant-diseases-under-organic-agriculture",totalDownloads:95,totalCrossrefCites:0,authors:[null]},{id:"80357",title:"Trchoderma Spp.: Their Impact in Crops Diseases Management",slug:"trchoderma-spp-their-impact-in-crops-diseases-management",totalDownloads:96,totalCrossrefCites:0,authors:[null]}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"287827",firstName:"Gordan",lastName:"Tot",middleName:null,title:"Mr.",imageUrl:"https://mts.intechopen.com/storage/users/287827/images/8493_n.png",email:"gordan@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2270",title:"Fourier Transform",subtitle:"Materials Analysis",isOpenForSubmission:!1,hash:"5e094b066da527193e878e160b4772af",slug:"fourier-transform-materials-analysis",bookSignature:"Salih Mohammed Salih",coverURL:"https://cdn.intechopen.com/books/images_new/2270.jpg",editedByType:"Edited by",editors:[{id:"111691",title:"Dr.Ing.",name:"Salih",surname:"Salih",slug:"salih-salih",fullName:"Salih Salih"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"117",title:"Artificial Neural Networks",subtitle:"Methodological Advances and Biomedical Applications",isOpenForSubmission:!1,hash:null,slug:"artificial-neural-networks-methodological-advances-and-biomedical-applications",bookSignature:"Kenji Suzuki",coverURL:"https://cdn.intechopen.com/books/images_new/117.jpg",editedByType:"Edited by",editors:[{id:"3095",title:"Prof.",name:"Kenji",surname:"Suzuki",slug:"kenji-suzuki",fullName:"Kenji Suzuki"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3828",title:"Application of Nanotechnology in Drug Delivery",subtitle:null,isOpenForSubmission:!1,hash:"51a27e7adbfafcfedb6e9683f209cba4",slug:"application-of-nanotechnology-in-drug-delivery",bookSignature:"Ali Demir Sezer",coverURL:"https://cdn.intechopen.com/books/images_new/3828.jpg",editedByType:"Edited by",editors:[{id:"62389",title:"PhD.",name:"Ali Demir",surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"872",title:"Organic Pollutants Ten Years After the Stockholm Convention",subtitle:"Environmental and Analytical Update",isOpenForSubmission:!1,hash:"f01dc7077e1d23f3d8f5454985cafa0a",slug:"organic-pollutants-ten-years-after-the-stockholm-convention-environmental-and-analytical-update",bookSignature:"Tomasz Puzyn and Aleksandra Mostrag-Szlichtyng",coverURL:"https://cdn.intechopen.com/books/images_new/872.jpg",editedByType:"Edited by",editors:[{id:"84887",title:"Dr.",name:"Tomasz",surname:"Puzyn",slug:"tomasz-puzyn",fullName:"Tomasz Puzyn"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3569",title:"Biodegradation",subtitle:"Life of Science",isOpenForSubmission:!1,hash:"bb737eb528a53e5106c7e218d5f12ec6",slug:"biodegradation-life-of-science",bookSignature:"Rolando Chamy and Francisca Rosenkranz",coverURL:"https://cdn.intechopen.com/books/images_new/3569.jpg",editedByType:"Edited by",editors:[{id:"165784",title:"Dr.",name:"Rolando",surname:"Chamy",slug:"rolando-chamy",fullName:"Rolando Chamy"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"44740",title:"Natural Products from Plants as Potential Source Agents for Controlling Fusarium",doi:"10.5772/52338",slug:"natural-products-from-plants-as-potential-source-agents-for-controlling-fusarium",body:'At present, due to the fast expansion of the world’s population, agricultural practices have been focused on increasing food production. Crop protection from competing weeds, insects and diseases has been necessary to obtain higher yields in agriculture. However, as a consequence of pest infection, a decrease in production performance has happened manifested in low food quality [1]. In order to solve this situation, synthetic chemical products have been widely used for controlling infectious diseases. Nonetheless environmental pollution due to their slow biodegradation, phytotoxicity, carcinogenicity and toxic waste in agricultural products is an important drawback [1, 2]. Agriculture production is currently trending to use eco-friendly methods for controlling diseases and pest infection [3, 4].
The growing demand of pesticide-free agricultural products has led to the search of novel, affordable, and less toxic strategies for pest control. Amongst those strategies biological agents, mineral salts and vegetable products have gained interest in the industry. Natural products are an important source of novel active chemical agents that could delay or inhibit pathogen growth and / or toxin production [5, 6]. Generally speaking, the plant derivatives (essential oils, extracts, fractions and compounds) are generally considered as non – phytotoxic and potentially effective for controlling pathogenic fungi in plants, [7]. Some of these natural subtances have showed antifungal, fungistatic or fungicidal activities which allow protected crops to have an extended shelf life by preventing enzymatic or metabolic processes of microorganisms. These fermentative or degradative microbiological processes can result not only in changes in odor taste, color and texture but also can cause potential harm to the consumer [8].
Natural compounds can be useful for crop and food protection. The use of botanicals for the management of the phytopathogens is gaining ground. Plant extracts and essential oils may have an important role to play in the preservation of foodstuffs against fungi. Recent literature has shown that biological activity of many plant-extracts, essential oils and their individual components is related with the inhibition of the growth of various fungi.From the 1970s there has been an increased interest on the study of the defensive mechanisms of plants for protecting against pathogenic agents or adverse environmental conditions. Phytochemical research has led to the isolation of active constituents synthesized by plants as a response to biotic or abiotic stresses, evidencing that these substances have insecticidal, fungicidal, bactericidal or herbicidal action. Throughout their evolution, plants have developed several defense mechanisms to prevent infections due to pathogens; also, plants synthesize a large number of secondary metabolites to protect themselves against biotic and abiotic stresses and for the maintenance of structure and vital functions. These are reasons to consider plants as an important source of new biopesticides [9, 10].
Fungi are a major cause of plant diseases and are responsible for significant economic losses to the food industry. These pathogens can cause local or systemic symptoms on their hosts. The most common symptoms are die-back (extensive necrosis of twigs), root-rot (disintegration or decay of the root system), leaf-spots (localized lesions on leaves consisting of death and collapsed cells), damping-off (rapid death of young seedlings), blight (general and extremely rapid browning death of leaves, branches, twigs, and floral organs), anthracnose (necrotic and sunken ulcer-like lesions of the stem, leaf, fruit, or flower), canker (localized necrotic lesion), basal stem rot (disintegration of the lower part of the stem), soft rots and dry rots (maceration and disintegration of fruits, roots, bulbs, tubers, and fleshy leaves) and decline (plants growing poorly, small and yellowish or red leaves) [11].
Species of the genus
This chapter consists of a literature survey of the antifungal potential against
The methods used to combat, control and prevent diseases in many crops by different strains of fungi, usually are divided into three groups according to the origin of the substance that makes the control. Currently, it is common the integral use of all kinds of control methods, practice that is known as integrated pest management. All methods have advantages and disadvantages, but the choice of a specific one for a particular crop depends on the state of the disease. In the following, a description of the chemical, biological and physical methods for controlling
Since the appearance in Europe of the fungus that caused the aggressive downy mildew disease of grape in the late 1870´s, many researchers have focused their efforts on the search for chemical entities that could control the diseases caused by fungal pathogens [11]. In particular, chemical fungicides have been used widely to control diseases caused by
Halogenated hydrocarbons are used as soil fumigants because of its fast spread. These compounds are used before the sowing of seeds as a sterilization system. The compounds most commonly used are methyl bromide 1 and trichloronitromethane 2, known as Chloropicrin, that were successfully employed in the treatment of root rot caused by different types of
However, the Enviromental Protection Agency classifies chloropicrin as a highly toxic and non-selective fungicide. The trichloronitro methane decomposes in the presence of light and heat and produces toxic gases like hidrogen chloride and nitrogen oxides. These compounds cause eye and skin irritation and adverse effects on the nervous system. Humans exposed for a long time to decomposition vapors of chloropicrin suffer severe headaches and pulmonary edema. Chloropicrin has a low accumulation in water due to its high volatility [21].
In the other hand, the Vienna Agreement of 1985 and the 1987 Montreal Protocol amended in London and Nairobi, classified the methyl bromide as a substance that ends up the ozone layer. Ozone (O3) is a molecule consisting of three oxygen atoms, formed naturaly in the upper layers of the atmosphere by the sun\'s energy; ozone is a very unstable molecule, the solar radiation decomposes the ozone into molecular oxygen and atomic oxygen, which react to form O3 again. The ozone’s concentration in the atmosphere depends on a dynamic equilibrium between the rate at which forms and the speed with which destroys. When methyl bromide reaches the ozone layer, sunlight decomposes the halogenated hydrocarbon generating bromine radical. The bromine radical reacts with an oxygen atom of the ozone molecule, inducing a radical reaction that destroys ozone molecules quickly. For the serious environmental consequences generated by the destruction of the ozone layer many countries have outright the use of methyl bromide as a pesticide; however the countries that permit the use of this substance as a pesticide should be implement environmental care measures. Exposure to methyl bromide causes headache, vomiting, skin irritation and damage to the central nervous system [22].
EBDC’s (Ethylenebisdithiocarbamates) are a group of non-systemic (surface acting) fungicides. EBDC active ingredients approved for their use are mancozeb, maneb, zineb and zineb ethylene thiuram disulphide adduct (metiram) [23]. The exact mechanism of action of EBDCs on fungi is not known. It is supposed that they act as fungicides when they are metabolised to an isothiocyanate radical (containing nitrogen-carbon-sulphur atoms) which inactivates the sulphydryl (sulphur-hydrogen) groups in amino acids (building blocks for proteins) contained within individual fungal pathogen cells [23]. Ethylenebisdithiocarbamates has been used for many years to control different diseases caused by
EBDCs have relatively low acute toxicity. They are categorised by the World Health Organization (WHO) as Class III unlikely to present an acute hazard in normal use. However, some studies of toxicity in mice of EBDC’s and some of their degradation products (like ethylenethiourea (ETU)) show that the principal target organ upon repeated exposure to all of the EBDCs is the thyroid [24]. For example, EBDCs and ETU altered thyroid hormone levels and/or weights in rats at the lowest dose after three months of dietary feeding. Other organs affected by ETU are liver at higher doses and pituitary gland: prolonged dietary feeding of ETU produces thyroid and pituitary tumors in rats and mice, and liver tumors in mice [23]. ETU is considered an industrial contaminant of the EBDCs’ industries.
Chemical structures of neonicotinoids are obtained by synthetic methods from nicotine, an alkaloid derived from ornithine and obtained naturally from
The benzimidazoles are organic compounds resulting from the fusion of an aromatic ring and an imidazole ring, widely known for its effective use as dewormers of mammals and some of its derivatives are recognized as important antifungal substances. Benzimidazoles interfere with cell division and intracellular transport mechanisms of pathogenic fungi. The active substance with antifungal activity of more widespread use with chemical structure derived from the benzimidazole is known as benomyl 4. It is a systemic foliar fungicide selectively toxic to microorganisms and invertebrates. Benomyl is used to treat vascular wilt of various crops (as tomato and carnation) caused by different special forms of
However, benzimadozoles show low mobility in soil and do not volatilize, therefore, they produce high accumulation. Their agrochemical registration was canceled in the United States and the European Union. Since 1982 the use of benomyl has been restricted in Sweden and New Zealand for the birth of children with malformation whose mothers were exposed to this pesticide. In Latin America it has been registered the use of benzimidazoles; however, since 2006 in Brazil is no longer authorized to use fungicide whose active ingredient is benomyl. According to the World Health Organization, benomyl is a fungicide that it is safe for mammals the LD50 is greater than 10000 mg/kg. Other international institutions such as the EPA and the Academy of Sciences of the United States of America classified the benomyl as teratogenic substance, and one of the twelve chemicals responsible for cancer in the USA [30].
Phenyl pyrroles are contact systemic fungicide used to control fungal phytopathogens, formulated mainly for
Biological control is defined as the use of living organism to eliminate or control other. These control methods become an option that reduces the risks to health and to the ecosystem, and in many cases produce effects comparable to synthetic chemical pesticides. Biological controllers alternatively can be used in combination with synthetic pesticides to reduce substantially the amount of chemical product applied. In the case of diseases caused by
The first one is given when the antagonist fungus consumes the root exudate of the host. As the exudate is the chemical signal that alerts the fungal pathogen to attack the plant, the infection does not happen.
When any fungal pathogen gets to cross the protective glove, it is destroyed and used as food by
The third type of protection is by exclusion, considering that
The previous considerations are very important because the biological control is a preventive but not curative methodology, therefore, when damage appears in plants must first be applied the chemical fungicide and seven days after
The Panamerican Agricultural School in Honduras has recorded, produced and developed a commercial fungicide based on
Free-living bacteria or associations that inhabit the rhizosphere can control natural inhabitants of soil as phytopathogenic fungi, like
In addition to chemical and biological control, there are physical methods, which normally are used as prevention methods and always should be used in combination with other methods of control. In the case of
Rotate crops: this method consist in planting of successive different crops in one field, following a defined order. In contrast, monoculture planting is repeated the same species in the same field year after year. The crop rotation is a practice that has positive effects on the crops, raise the production due to: Reducing the incidence of pest and diseases, to stop their cycle’s life. Provides a better nutrients soil profile. Allows balancing the production of waste and when the crop is contaminated with a pathogen, the crop rotation provides a partial reduction of pathogen inoculums [37]. In the specific case of affected crops by
Planting bed: this method is commonly used in many countries of Latin America to control
Solarization: according to the FAO, soil solarization is a term that refers to soil disinfestation by heat generated from solar energy captured. Soil solarization is a hydrothermal process that takes place in moist soil which is covered by a plastic film and exposed to sunlight during the warmer months [40]. The efficiency of soil solarization to control soil pests depends on the relationship between exposure time and temperature. This method is based on the fact that many pathogens are mesophiles in which a threshold temperature of 37 0C is critical and the accumulation of the effects of heat at that temperature or higher is lethal. It is important to note that there are thermophilic and thermotolerant organisms that can survive and even thrive at this temperature.This method has the advantage that it is not dangerous for farmers and does not transmit toxic waste to the consumers, being easy to educate farmers about their use. However, some disadvantages of this method are the lack of sufficient irrigation water and the survival of the pathogen in the deeper soil layers. For
It is clear that chemical control methods are most effective for the treatment of diseases caused by
Several methods for testing antifungal susceptibility are currently used. So far, key areas for the application of antifungal bioassays include control of crop pathogens in phytopathology and human pathogenic fungi in antimycotic chemotherapy. Fungicidal testing includes either
The available methods for detecting activity are not equally sensitive or not based upon the same principle; therefore results will be profoundly influenced by the method. The choice of assay constitutes the first arising difficulty when working with fungi. One of the most inherent problems is that the single methodologies do not really produce comparable results. The standardization of antifungal susceptibility testing methods is crucial for the evaluation and development of antifungal drugs and agrochemicals, because the successful use of a fungicide usually also requires the dissemination of its correct application procedure [42, 44].
The ability of a compound to kill a pathogen as opposed to simply inhibiting its growth is an apparently desirable quality, particularly in the setting of decreased immunity. Although several studies have characterized the fungicidal activity of antifungal agents, there is no standardized method for doing so [43].
Below is a description of the main features of methods to evaluate antifungal activity. The most used assays to detect antifungal substances are bioautography, disk diffusion, agar dilution and dilution tests. These antifungal test methods have been classified into three main groups: dilution, diffusion and bioautographic methods [44, 45].
Dilutions assays, especially those that are carried out in microwell plates, are one of the most useful and efficient methodologies to evaluate antifungal activity of different substances [45, 46, 47].
In the dilution methods, the compounds are mixed with an appropriate medium that has been previously inoculated with the fungal strain. The assay can be carried out in liquid as well as in solid media. The results of these assays can be measured in many ways; being the minimal inhibitory concentration (MIC) and half effective concentration (EC50) the most common forms of reporting results. Minimal inhibitory concentration (MIC) is defined as the lowest concentration capable to inhibit any fungal growth. Half effective concentration is defined as the the median concentration that causes 50 % of maximal response in a given system.
In liquid or broth-dilution methods, turbidity and redox-indicators are most commonly used. Turbidity can be estimated visually or achieved more accurately by measuring the optical density at 405 nm. However, test samples that are not entirely soluble may interfere with turbidity readings, emphasizing the need for a negative control or sterility control. The liquid-dilution method also determines whether a compound or extract has a fungicidal or static action at a particular concentration. The serial dilution test yielded the best reproducible results on the MIC and was recommended as general standard methodology for testing natural products. The microdilution method is more sensitive and allows detecting the MIC more exactly [45].
This technique is one of the most widely employed for antifungal activity screening, due to its simplicity and low cost. It is primarily used to determine if a compound or a compound mixture (like crude extracts, fractions and essential oils) possesses any activity. This assay is based on the use of disks containing solutions of the substances to be evaluated. The tested substance, at a known concentration, is in contact with an inoculated medium, and the diameter of the clear inhibition zone around the reservoir (inhibition diameter) is measured at the end of the incubation period. The results of this assay also can be reported as Minimal Inhibitory Quantity (MIQ) which is deffined as the minimal quantity of substance that causes some detectable inhibition of fungal growth. One of the major shortcomings of these methodologies is that, as for all diffusion assays, the concentration of the compound or compound mixture tested is unknown [42, 44].
The possibility to test up to six extracts per plate against a single microrganism and the use of small sample volumes are specific advantages of diffusion assays [45]. The diffusion method is not appropriate for testing non-polar samples or samples that do not easily diffuse into agar. The antimicrobial potency of different samples may not always be compared, mainly because their differences in physical properties, such as solubility, volatility and diffusion characteristics in agar. Additionally, size of inhibition zones might be influenced by volatilization of antimicrobial active test material. Due to the absolute values of inhibition zones have only relative importance, the agar diffusion method is appropriate as pre-test only and should not be used for compounds of high lipophilicity, such as volatile sesquiterpenes [48]. Furthermore, agar-diffusion methods are difficult to run on high-capacity screening plataforms.
The composition of the medium could influence the activity of the tested substances. The agar diffusion assay is limited to substances with considerable water solubility. Growth media and compound doses employed in this test system vary much and hamper the interpretation of results. On the other hand, the disk diffusion method was used as a laboratory routine to perform a susceptible test for licensed drugs
The inhibition zones are usually distorted as this application procedure does not guarantee the test compound to be evenly distributed across the disk. However, if the solvent has not been removed properly and causes inhibition effects by itself, the zones are highly concentric to the disk. The peculiarity of this phenomenon facilitates the experienced researcher to become aware of the deficiency in his work [42].
Conventionally, diameters of inhibition zones are presented to document the observed antifungal activity. In interpreting these diameters, should be considered that variable diffusion properties of the test compound may affect the outcome, especially if results from this assay are used to compare MIC values of different compounds. There exist modifications of this method, such as the agar well diffusion, including the hole-plate (diffusion of the aqueous test compound solution into the agar medium from a vertical hole in the agar layer) and the cylinder method (stainless-steel or ceramic cylinders placed on top of the agar medium) [50]. These two modifications have their merits when the test compound shows good solubility in aqueous solvents. However, as the majority of active compounds are better soluble in organic solvents, the addition of a specific portion of organic solvent to obtain an aqueous suspension of the test compound is required. This modification has the evident advantage that pure organic solvent can be used for the stock solution, which gets completely lost during the preparation of the disks after efficient drying [42].
This technique was introduced by Homans and Fuchs (1970) and is preferably carried out on thin-layer plates (TLC), but is also applicable on polyacrylamide gels [51, 52]. The bioautography can be done in three ways: (a) direct bioautography, where the microorganism grows directly on the thin-layer-chromatographic plate (TLC); (b) contact bioautography, where the antimicrobial compounds are transferred from the TLC plate to an inoculated agar plate through direct contact and (c) agar-overlay bioautography, where a seeded agar medium is applied directly onto the TLC plate. TLC has an enormous potential for separating mixtures of low-molecular weight compounds, reason that bioautography allows localizing substances with antimicrobial activity of an extract on the chromatogram; it supports a quick search for new antimicrobial agents through bioassay-guided isolation [44].
Autobiography on TLC plates facilitates the evaluation of a wide range of filamentous fungi to antifungal testing. Preference is given to those fungi that are characterized by pigmented hyphae, spores or conidia; if contrast is poor, it can be enhanced by treatments with iodine vapor [42]. The fungus is applied to the plates in a suspension, that usually consists of malt extract broth or glucose medium with mineral salts added [51]. However, the nutrient medium composition may have to be adjusted to the specific requirements of each test fungus.
Wedge and Nagle published the application of 2D-TLC as efficient approach to obtain improved separation of compounds with a concomitant gain in sensitivity of the assay [53]. Diffusion assays are generally less suitable to assess the quality of the antifungal activity in comparison to positive controls, despite their quick and versatile application.
Apart from the advantages of rapidly detecting active compounds in mixtures and high sensitivity, the depicted bioautography also points to a potential disadvantage of this diffusion assay. Its applicability is limited to microorganisms that easily grow on TLC plates. The diffusion effects may significantly hamper a comparison of activities between different compounds with differing chemical properties. Another factor that may also affect results is the stability of the compound on the TLC plate as the duration of the assay may last for several days and exact quantization of the amounts of the compound that survived on the TLC plate are rarely performed due to the amount of effort required. This qualitative technique is not directly applicable in current high capacity screening designs and does not give data of values for Minimal Inhibitory Concentration (MIC). When pure compounds are evaluated at diferentt quantities in this assay, the results of its activity can be reported as Minimal Inhibitory Quantity (MIQ) which is deffined as the minimal quantity of substance that causes some detectable inhibition of fungal growth [54, 55].
Flow cytometry (FC) has been described as an excellent tool for studying the susceptibility of different microorganisms, including fungi [48, 49]. The main advantages of FC are: 1) it yields higher susceptibility and precise results and 2) FC assays combine the speed of cell-by-cell analysis of very large populations with the independence from long incubation times, resulting in faster tests. However, there are still determinant disadvantages such as: the extremely high cost of the FC equipment, besides that, and in spite of the evolutions made in recent times regarding the user-equipment interface, the techniques still require an experience and skilled operator in order to obtain optimal results [56].
Natural plant products have been used since the fifteenth century by different communities to control different pests. Today, interest in botanical pesticides has come back, reason why many phytochemical investigations have been focused on finding new products with pesticidal properties. It is important to note that many antifungal activity assays are used to determine the fungicidal potential of a substance, therefore, the results of antifungal activity forextracts, fractions, essential oils and pure compounds are reported in many ways, making difficult to compare results, in order to establish which substances are most promising to control fungi. The following sections present a review of studies of antifungal activity of different products from plants evaluated against different
This section presents a review of the main results of antifungal activity of plant extracts and fractions that have been carried out in recent years. Some crude extracts from species of families Asteraceae, Rubiaceae, Rosaceae, Rutaceae, among other have excellent activities
The diffusion method is the most employed technique in the screening to the antifungal activity in extracts or fractions, because it is a fast - low cost assay and allows an approach to the presence of active compounds. Table 1 summarizes the main results of antifungal activity against species of
The antifungal activity of extracts of four plants from Lake Manzalah in Egypt was tested
Leaves | Aqueous | Inhibition diameter (ID) | 45.0 mm (300 mg/mL) | 57 | |||
Chloroform | 23.0 mm (300 mg/mL) | ||||||
Ethanolic | 24.0 mm (300 mg/mL) | ||||||
Methanolic | 11.0 mm (300 mg/mL) | ||||||
Leaves | Ethanol | Minimum inhibitory quantity (MIQ) | 250 µg | 58 | |||
Steam | Alcaloids fracction | MIQ | 500 µg | 59 | |||
Chloroform | 500 µg | ||||||
Leaves | Ethanolic | MIQ | 500 µg | 59 | |||
Leaves | Ethanolic | MIQ | 100 µg | 58 y 59 | |||
Petroleum ether | 100 µg | ||||||
Chloroform | 500 µg | ||||||
500 µg | |||||||
Wood | Ethanolic | 250 µg | |||||
Hexane | 250 µg | ||||||
Chloroform | 100 µg | ||||||
100 µg | |||||||
Fruits | Ethanolic | MIQ | 250 µg | 58 | |||
Leaves | 250 µg | ||||||
Roots | 250 µg | ||||||
Leaves | 250 µg | ||||||
Leaves | 100 µg | ||||||
Fruits | 250 µg | ||||||
Aerial part | 100 µg | ||||||
Wood | 250 µg | ||||||
Aerial part | 100 µg | ||||||
Leaves | Aqueous | ID | 44.0 mm (300 mg/mL) | 57 | |||
Ethanolic | 12.0 mm (300 mg/mL) | ||||||
Methanolic | 14.0 mm (300 mg/mL) | ||||||
Leaves | Aqueous | ID | 48.0 mm (300 mg/mL) | 57 | |||
Chloroform | 11.0 mm (300 mg/mL) | ||||||
Ethanol | 16.0 mm (300 mg/mL) | ||||||
Methanol | 21.0 mm (300 mg/mL) | ||||||
Leaves | Aqueous | ID | 38.0 mm (300 mg/mL) | 57 | |||
Chloroform | 28.0 mm (300 mg/mL) | ||||||
Methanol | 26.0 mm (300 mg/mL) | ||||||
Shoots | Metanolic Fenols fraction | ID | 10.7 mm ( 35 mg/mL) | 61 | |||
24.3 mm ( 35 mg/mL) | |||||||
11.7 mm (35 mg/mL) | |||||||
18.0 mm 35 mg/mL) | |||||||
Leaves | Ethanolic | MIQ | 500 µg | 59 | |||
Alkaloids – CHCl3 | 250 µg | ||||||
Wood | Ethanolic | 500 µg | |||||
Ethyl acetate | 100 µg | ||||||
Acetone | 500 µg | ||||||
Bark | Ethanolic | MIQ | 250 µg | 58 y 59 | |||
250 µg | |||||||
Bark | Ethanolic | MIQ | 500 µg | 59 | |||
Wood | Ethanolic | MIQ | 250 µg | 58 | |||
Leaves | Ethanolic | MIQ | 500 µg | 59 |
Results of diffusion method (inhibition grown or minimum inhibitory quantity) of plant extracts and fractions against
In a study of the antifungal activity against
Plants species of
The dilution method is used to determine more specifically the activity of an extract or fraction. In this technic, minimum inhibitory concentrations MIC are determined by agar-dilution method or microdilution method. The results of the antifungal activity using dilution methods are summarize in Table 2.
Leaves | Acetone | Minimum inhibitory concentration MIC | 0.63 mg/mL | 62 | |||||||
Methanol | 0.32 mg/mL | ||||||||||
Hexane | 0.32 mg/mL | ||||||||||
Dichloromethane | 0.32 mg/mL | ||||||||||
Aerial part | Methanolic | % inhibition | 67 % (8,4 mg/mL) | 64 | |||||||
Leaves | Ethanolic | % Inhibition | 85 % (100 μl/l) | 65 | |||||||
80 % (100 μl/l) | |||||||||||
90 % (100 μl/l) | |||||||||||
Leaves | Acetone | MIC | 0.08 mg/mL | 62 | |||||||
Methanol | 0.63 mg/mL | ||||||||||
Hexane | 0.32 mg/mL | ||||||||||
Dichloromethane | 0.16 mg/mL | ||||||||||
Fruits | Ethanolic | % Inhibition | 70 % (50 mg/mL) | 66 | |||||||
Leaves | Aqueous | % Inhibition | 74 % (3,33 mg/mL) | 67 | |||||||
69 % (3,33 mg/mL) | |||||||||||
60 % (3,33 mg/mL) | |||||||||||
60 % (3,33 mg/mL) | |||||||||||
Leaves | Acetone | MIC | 0.02 mg/mL | 62 | |||||||
Methanol | 0.63 mg/mL | ||||||||||
Hexane | 0.32 mg/mL | ||||||||||
Dichloromethane | 0.04 mg/mL | ||||||||||
Leaves | Aqueous | % Inhibition | 75 % (3,33 mg/mL) | 67 | |||||||
71 % (3,33 mg/mL) | |||||||||||
64 % (3,33 mg/mL) | |||||||||||
69 %(3,33 mg/mL) | |||||||||||
79 % (3,33 mg/mL) | |||||||||||
89 % (3,33 mg/mL) | |||||||||||
80 % (3,33 mg/mL) | |||||||||||
76 % (3,33 mg/mL) | |||||||||||
Leaves | Aqueous | % Inhibition | 62 % (3,33 mg/mL) | 67 | |||||||
69 % (3,33 mg/mL) | |||||||||||
76 % (3,33 mg/mL) | |||||||||||
66 % (3,33 mg/mL) | |||||||||||
81 % (3,33 mg/mL) | |||||||||||
Leaves | Aqueous | % Inhibition | 76 % (3,33 mg/mL) | 67 | |||||||
72 % (3,33 mg/mL) | |||||||||||
70 % (3,33 mg/mL) | |||||||||||
90 % (3,33 mg/mL) | |||||||||||
80 % (3,33 mg/mL) | |||||||||||
91 % (3,33 mg/mL) | |||||||||||
81 % (3,33 mg/mL) | |||||||||||
80 % (3,33 mg/mL) | |||||||||||
Leaves | Acetone | % Inhibition | 0.08 mg/mL | 62 | |||||||
Methanol | 0.63 mg/mL | ||||||||||
Hexane | 0.32 mg/mL | ||||||||||
Dichloromethane | 0.16 mg/mL | ||||||||||
Leaves | Acetone | MIC | 0.32 mg/mL | 62 | |||||||
Methanol | 0.08 mg/mL | ||||||||||
Hexane | 0.16 mg/mL | ||||||||||
Dichloromethane | 0.16 mg/mL | ||||||||||
Leaves | Aqueous | % Inhibition | 86 % (3,33 mg/mL) | 67 | |||||||
70 % (3,33 mg/mL) | |||||||||||
78 % (3,33 mg/mL) | |||||||||||
79 % (3,33 mg/mL) | |||||||||||
86 % (3,33 mg/mL) | |||||||||||
93 % (3,33 mg/mL) | |||||||||||
84 % (3,33 mg/mL) | |||||||||||
80 % (3,33 mg/mL) | |||||||||||
Stems | Ethanolic | % Inhibition | 60 % (5,0 mg/mL) | 66 | |||||||
Leaves | 70 % (5,0 mg/mL) | ||||||||||
flowers | 80 % (5,0 mg/mL) |
Results of dilution method (percentage of inhibition or minimum inhibitory concentration) of plant extracts and fractions against
The antifungal activity of acetone, methanol, hexane and dichloromethane leaf extracts of six African plants,
The genus
Aqueous extracts of 46 plants belonging to 32 different families were tested for antifungal activity against eight species of
Amongst alternatives for natural biological control, are found essential oils and their components, which have showed therapeutic activities and toxicity facing fungi, bacteria and insects. These substances could be an alternative to inhibit pathogen fungi growth such as Fusarium species. They have as advantages specificity, evaporation (avoiding residues) and biodegradability; and furthermore they are considered non aggressive from the standpoint of health. Although their action mechanisms are not totally clear, it has been reported that chemical components present in essential oils produces the following effects: protein denaturalization in the cell membrane, precipitation of cell proteins and enzymatic inhibition, provoking the loss of amino acids [68, 69, 70]. Thus, each component in an essential oil has its own contribution upon the whole biological activity. Amongst those reported compounds that showed antimicrobial properties are found thymol, carvacrol, geranial, citronellal, geraniol, linalool, citronellol and lavandulol [6].
Despite the advantages that have essential oils for control of fungal pathogens, their use as commercial products is still incipient, due to its high cost-benefit ratio due to the low extraction yields of essential oils. Another reason is the low development of efficient formulations to maintain its effective concentration for long periods of time, due to that essential oils: they are very complex mixtures, they have high evaporation rate and they degrade quickly even at room temperature. At present they has proposed the use of waxes that are widely used in the food industry for incorporate the essential oils. It has also been proposed to prepare emulsions with controlled release of essential oils, as part of the solution to counteract some of the above mentioned disadvantages [71].
The following will be a review of essential oils that could be considered as an alternative for plant disease control produced by Fusarium genus fungi. Among the plants that are important for its antifungal activity are found the plants of the families Annonaceae, Apiaceae, Asclepidaceae, Asteraceae, Caryphyllacaeae, Cupresaceae, Chenopodiaceae, Geraniaceae, Lamiaceae, Lauraceae, Myrtaceae, Piperaceae, Poaceae, Rosaceae, Rutaceae, Solanaceae Unmbeliferacea, Verbenaceae and Zingiberaceae. Lamiaceae family is the one with the largest number of antifungal activity reports, with studies of species belonging to genera
Also was observed that
The information from the review are shown on Tables 3 and 4, according to the type of assay used, such as previously was described in section 3. In the tables is possible to see that the assay most commonly used for evaluate the antifungal activity of essential oils was the dilution method (Table 3).
Leaves | Hydrodistillation | Percentaje of growth inhibition | 100% (500 μL/L) | 72 | |||
Seeds | 66% (500 μg/mL ) | 73 | |||||
Whole plant | Steam distillation | Percentaje of growth inhibition | 92% (1000 μg/mL) | 74 | |||
No report | 88% (1 μg/mL) | 75 | |||||
94% (1 μg/mL) | |||||||
Comercial | MFC | 72 μg/mL | 6 | ||||
202 μg/mL | |||||||
96 μg/mL | |||||||
75 μg/mL | |||||||
99 μg/mL | |||||||
77 μg/mL | |||||||
151 μg/mL | |||||||
73 μg/mL | |||||||
69 μg/mL | |||||||
63 μg/mL | |||||||
Whole plant | Steam distillation | Percentaje of growth inhibition | 83% (1000μg/mL) | 74 | |||
Comercial | MFC | 70 μg/mL | 6 | ||||
952 μg/mL | |||||||
795 μg/mL | |||||||
Whole plant | Steam distillation | Percentaje of growth inhibition | 100% (500μg/mL) | 74 | |||
Aerial part | Hydrodistillation | MIC | 3,6 μg/mL | 76 | |||
Whole plant | Steam distillation | Percentaje of growth inhibition | 89% (1000μg/mL) | 74 | |||
67% (1000μg/mL) | |||||||
Leaves | 78% (400 μg/disco) | 77 | |||||
89% (400 μg/disco) | |||||||
Flowers | 98% (400 μg/disco) | ||||||
95% (400 μg/disco) | |||||||
76% (1000μg/mL) | 74 | ||||||
Whole plant | 76% (1000μg/mL) | ||||||
Flowers | Hydrodistillation | MIC | 500 μg/mL | 7 | |||
125 μg/mL | |||||||
Berries | Hydrodistillation | MIC | 10 μg/mL | 78 | |||
Floral cones | 500 μL/mL | 79 | |||||
500 μl/mL | |||||||
Leaves | Hydrodistillation | Percentaje of growth inhibition | 100% (100 μg/mL) | 80 | |||
No report | Percentaje of growth inhibition | 86% (1 μg/mL) | 75 | ||||
74% (1 μg/mL) | |||||||
Leaves | Hydrodistillation | F. oxysporum sp. gladioli | Percentaje of growth inhibition | 100% (0,6 μL/mL) | 81 | ||
Leaves | Hydrodistillation | EC50 | 520 μg/mL | 82 | |||
No report | Percentaje of growth inhibition | 69% (1 μg/mL) | 75 | ||||
Aerial part | Hydrodistillation | 100% (3.12 μg/mL) | 83 | ||||
Leaves | MIC | 63 μg/mL | 84 | ||||
63 μg/mL | |||||||
31 μg/mL | |||||||
EC50 | 400 μg/mL | 82 | |||||
Commercial | Percentaje of growth inhibition | 83% (300 μg/mL) | 70 | ||||
No report | Steam distillation | 77% (1000 μg/mL) | 74 | ||||
No report | 98% (1 μg/mL) | 75 | |||||
92% (1 μg/mL) | |||||||
No report | Steam distillation | 67% (1000 μg/mL) | 74 | ||||
No report | 75% (1 μg/mL) | 75 | |||||
78% (1 μg/mL) | |||||||
Leaves | Hydrodistillation | 100% (5 μL/mL) | 85 | ||||
Flowers | 100% (5 μL/mL) | ||||||
Leaves | 100% (5 μL/mL) | ||||||
Flowers | 100% (5 μL/mL) | ||||||
Aerial part | MIC | 56 μg/mL | 86 | ||||
SFME | 57 μg/mL | ||||||
Leaves | Hydrodistillation | Percentaje of growth inhibition | 75% (5 μL/mL) | 80 | |||
Flowers | 75% (5 μL/mL) | ||||||
Leaves | 75% (5 μL/mL) | ||||||
Leaves | 100% (500 μL/mL) | 87 | |||||
Leaves | EC50 | 76 μg/mL | 82 | ||||
Leaves | 120 μg/mL | ||||||
Leaves | 50 μg/mL | ||||||
Aerial parts | MIC | 63 μg/mL | 88 | ||||
63μg/mL | |||||||
31 μg/mL | |||||||
Leaves | 500 μg/mL | 89 | |||||
Stems | 500 μg/mL | ||||||
Aerial part | Steam distillation | Percentaje of growth inhibition | 100% (125 μg/mL) | 90 | |||
Leaves | Hydrodistillation | EC50 | 668 μg/mL | 82 | |||
Aerial part | MIC | 100 μL/mL | 91 | ||||
0.63 μL/mL | 92 | ||||||
No report | Percentaje of growth inhibition | 65% (1 μg/mL) | 75 | ||||
Aerial part | Steam distillation | MIC | 450 μg/mL | 93 | |||
Leaves | Hydrodistillation | EC50 | 71 μg/mL | 82 | |||
Whole plant | MIC | 125 μg/mL | 94 | ||||
125 μg/mL | |||||||
63 μg/mL | |||||||
Whole plant | Percentaje of growth inhibition | 100% (600 μg/mL) | 73 | ||||
Commercial | 100% (200 μg/mL) | 70, 95 | |||||
100% (100 μg/mL) | |||||||
No report | 98% (1 μg/mL) | 75 | |||||
98% (1 μg/mL) | |||||||
Whole plant | Steam distillation | 100% (250 μg/mL) | 84 | ||||
No |